{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:27:06Z","timestamp":1781022426843,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005292","name":"Brigham and Women&apos;s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijcard.2023.131698","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T12:27:05Z","timestamp":1704371225000},"page":"131698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial"],"prefix":"10.1016","volume":"399","author":[{"given":"Benedikt","family":"Bernhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobak","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaib","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Lumish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jerosch-Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2023.131698_bb0005","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.CIR.0000036014.90197.FA","article-title":"Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications","volume":"106","author":"Bolognese","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0010","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00330-018-5875-3","article-title":"Prognosis-based definition of left ventricular remodeling after ST-elevation myocardial infarction","volume":"29","author":"Reindl","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0015","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/01.CIR.0000070420.51787.A8","article-title":"Left ventricular remodeling and ventricular arrhythmias after myocardial infarction","volume":"107","author":"St John Sutton","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0020","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.131698_bb0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0030","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0035","doi-asserted-by":"crossref","first-page":"1d","DOI":"10.1016\/0002-9149(91)90255-J","article-title":"Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management","volume":"68","author":"Braunwald","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12937-019-0455-1","article-title":"Omega-3 intake is associated with attenuated inflammatory response and cardiac remodeling after myocardial infarction","volume":"18","author":"Campos-Staffico","year":"2019","journal-title":"Nutr. J."},{"key":"10.1016\/j.ijcard.2023.131698_bb0045","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0891-5849(03)00407-6","article-title":"Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects","volume":"35","author":"Mori","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2023.131698_bb0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCULATIONAHA.115.019949","article-title":"Effect of omega-3 acid ethyl esters on left ventricular remodeling after acute myocardial infarction: the OMEGA-REMODEL randomized clinical trial","volume":"134","author":"Heydari","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0055","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurjhf\/hfq172","article-title":"Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial","volume":"12","author":"Ghio","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2023.131698_bb0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vph.2016.01.005","article-title":"Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; A randomized clinical trial","volume":"79","author":"Chrysohoou","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcdr.2013.02.013","article-title":"Effect of omega-3 on brain natriuretic peptide and echocardiographic findings in heart failure: double-blind placebo-controlled randomized trial","volume":"4","author":"Kojuri","year":"2013","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"10.1016\/j.ijcard.2023.131698_bb0070","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0075","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"N-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.131698_bb0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.120.052209","article-title":"Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized, controlled trial","volume":"143","author":"Kalstad","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0085","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0090","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","author":"GISSI-Prevenzione Investigators","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.131698_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ajcn\/74.1.50","article-title":"Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol","volume":"74","author":"Nilsen","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ijcard.2023.131698_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1007757724505","article-title":"Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4","volume":"11","author":"Singh","year":"1997","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2023.131698_bb0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12872-019-1086-3","article-title":"Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis","volume":"19","author":"Popoff","year":"2019","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2023.131698_bb0110","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.amjcard.2019.11.032","article-title":"Insulin resistance modifies the effects of omega-3 acid ethyl esters on left ventricular remodeling after acute myocardial infarction (from the OMEGA-REMODEL randomized clinical trial)","volume":"125","author":"Fujikura","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0115","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijcard.2012.09.076","article-title":"Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction","volume":"168","author":"Harris","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCOUTCOMES.109.896159","article-title":"Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the heart and soul study","volume":"3","author":"Pottala","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2023.131698_bb0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","article-title":"The omega-3 index: a new risk factor for death from coronary heart disease?","volume":"39","author":"Harris","year":"2004","journal-title":"Prev. Med."},{"key":"10.1016\/j.ijcard.2023.131698_bb0135","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/01.CIR.0000142292.10048.B2","article-title":"Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/nu6020799","article-title":"Omega-3 index and cardiovascular health","volume":"6","author":"Von Schacky","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.ijcard.2023.131698_bb0145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11745-006-1392-2","article-title":"The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes","volume":"40","author":"Sands","year":"2005","journal-title":"Lipids"},{"key":"10.1016\/j.ijcard.2023.131698_bb0150","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.1995.03530170043030","article-title":"Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest","volume":"274","author":"Siscovick","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2023.131698_bb0155","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","article-title":"Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)","volume":"2","author":"Burr","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.131698_bb0165","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.131698_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.119.044440","article-title":"REDUCE-IT USA: results from the 3146 patients randomized in the United States","volume":"141","author":"Bhatt","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.131698_bb0175","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.jacc.2019.02.032","article-title":"Effects of Icosapent ethyl on Total ischemic events: from REDUCE-IT","volume":"73","author":"Bhatt","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0180","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ijcard.2023.131698_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2023.131698_bb0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/eurheartj\/ehaa1011","article-title":"Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study","volume":"42","author":"Schubert","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.131698_bb0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.plefa.2019.01.002","article-title":"Association of reported fish intake and supplementation status with the omega-3 index","volume":"142","author":"Jackson","year":"2019","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ijcard.2023.131698_bb0200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1017\/S0007114510001054","article-title":"Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index","volume":"104","author":"K\u00f6hler","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ijcard.2023.131698_bb0205","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2012.05.030","article-title":"Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham heart study","volume":"225","author":"Harris","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2023.131698_bb0210","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1503734","article-title":"Fish oil-derived fatty acids in pregnancy and wheeze and asthma in offspring","volume":"375","author":"Bisgaard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.131698_bb0215","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ajcn\/88.4.941","article-title":"FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease","volume":"88","author":"Martinelli","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ijcard.2023.131698_bb0220","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2019.06.043","article-title":"Reduction in first and Total ischemic events with icosapent ethyl across baseline triglyceride tertiles","volume":"74","author":"Bhatt","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.131698_bb0230","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.jacc.2022.09.048","article-title":"Micronutrient supplementation to reduce cardiovascular risk","volume":"80","author":"An","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0235","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/s41467-021-22370-2","article-title":"Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies","volume":"12","author":"Harris","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijcard.2023.131698_bb0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2021.07.036","article-title":"Sex-related differences in ventricular remodeling after myocardial infarction","volume":"339","author":"Aimo","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131698_bb0245","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jacc.2009.09.065","article-title":"Sex-related differences in myocardial remodeling","volume":"55","author":"Piro","year":"2010","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323018569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323018569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:05:02Z","timestamp":1759093502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323018569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":49,"alternative-id":["S0167527323018569"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131698","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131698"}}